Literature DB >> 9817926

Temperature-sensitive mutation in PEX1 moderates the phenotypes of peroxisome deficiency disorders.

A Imamura1, S Tamura, N Shimozawa, Y Suzuki, Z Zhang, T Tsukamoto, T Orii, N Kondo, T Osumi, Y Fujiki.   

Abstract

The peroxisome biogenesis disorders (PBDs), including Zellweger syndrome (ZS), neonatal adrenoleukodystrophy (NALD) and infantile Refsum disease (IRD), are autosomal recessive diseases caused by deficiency of peroxisome assembly as well as malfunction of peroxisomes, where >10 genotypes have been reported. ZS patients manifest the most severe clinical and biochemical abnormalities, while those with NALD and IRD show the least severity and the mildest features, respectively. PEX1 is the causative gene for PBDs of complementation group I (CG1), the highest incidence PBD, and encodes the peroxin, Pex1p, a member of the AAA ATPase family. In the present work, we found that peroxisomes were morphologically and biochemically formed at 30 but not 37 degrees C, in the fibroblasts from all CG1 IRD patients examined, whereas almost no peroxisomes were seen in ZS and NALD cells, even at 30 degrees C. A point missense mutation, G843D, was identified in the PEX1 allele of most CG1 IRD patients. The mutant PEX1, termed HsPEX1G843D, gave rise to the same temperature-sensitive phenotype on CG1 CHO cell mutants upon transfection. Collectively, these results demonstrate temperature-sensitive peroxisome assembly to be responsible for the mildness of the clinical features of PEX1 -defective IRD of CG1.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9817926     DOI: 10.1093/hmg/7.13.2089

Source DB:  PubMed          Journal:  Hum Mol Genet        ISSN: 0964-6906            Impact factor:   6.150


  18 in total

Review 1.  The role of chaperone-assisted folding and quality control in inborn errors of metabolism: protein folding disorders.

Authors:  N Gregersen; P Bross; B S Andrese; C B Pedersen; T J Corydon; L Bolund
Journal:  J Inherit Metab Dis       Date:  2001-04       Impact factor: 4.982

2.  Phenotype-genotype relationships in peroxisome biogenesis disorders of PEX1-defective complementation group 1 are defined by Pex1p-Pex6p interaction.

Authors:  S Tamura; N Matsumoto; A Imamura; N Shimozawa; Y Suzuki; N Kondo; Y Fujiki
Journal:  Biochem J       Date:  2001-07-15       Impact factor: 3.857

3.  A novel PEX12 mutation identified as the cause of a peroxisomal biogenesis disorder with mild clinical phenotype, mild biochemical abnormalities in fibroblasts and a mosaic catalase immunofluorescence pattern, even at 40 degrees C.

Authors:  Avraham Zeharia; Merel S Ebberink; Ronald J A Wanders; Hans R Waterham; Alisa Gutman; Andreea Nissenkorn; Stanley H Korman
Journal:  J Hum Genet       Date:  2007-05-30       Impact factor: 3.172

Review 4.  Peroxisome Biogenesis Disorders.

Authors:  Masanori Honsho; Kanji Okumoto; Shigehiko Tamura; Yukio Fujiki
Journal:  Adv Exp Med Biol       Date:  2020       Impact factor: 2.622

Review 5.  Clinical, biochemical and genetic aspects and neuronal migration in peroxisome biogenesis disorders.

Authors:  Y Suzuki; N Shimozawa; A Imamura; S Fukuda; Z Zhang; T Orii; N Kondo
Journal:  J Inherit Metab Dis       Date:  2001-04       Impact factor: 4.982

6.  The PEX1 ATPase Stabilizes PEX6 and Plays Essential Roles in Peroxisome Biology.

Authors:  Mauro A Rinaldi; Wendell A Fleming; Kim L Gonzalez; Jaeseok Park; Meredith J Ventura; Ashish B Patel; Bonnie Bartel
Journal:  Plant Physiol       Date:  2017-06-09       Impact factor: 8.340

7.  Disorders of peroxisome biogenesis due to mutations in PEX1: phenotypes and PEX1 protein levels.

Authors:  C Walter; J Gootjes; P A Mooijer; H Portsteffen; C Klein; H R Waterham; P G Barth; J T Epplen; W H Kunau; R J Wanders; G Dodt
Journal:  Am J Hum Genet       Date:  2001-06-01       Impact factor: 11.025

8.  Mutations in novel peroxin gene PEX26 that cause peroxisome-biogenesis disorders of complementation group 8 provide a genotype-phenotype correlation.

Authors:  Naomi Matsumoto; Shigehiko Tamura; Satomi Furuki; Non Miyata; Ann Moser; Nobuyuki Shimozawa; Hugo W Moser; Yasuyuki Suzuki; Naomi Kondo; Yukio Fujiki
Journal:  Am J Hum Genet       Date:  2003-07-08       Impact factor: 11.025

9.  Infantile Refsum Disease: Influence of Dietary Treatment on Plasma Phytanic Acid Levels.

Authors:  Maria João Nabais Sá; Júlio C Rocha; Manuela F Almeida; Carla Carmona; Esmeralda Martins; Vasco Miranda; Miguel Coutinho; Rita Ferreira; Sara Pacheco; Francisco Laranjeira; Isaura Ribeiro; Ana Maria Fortuna; Lúcia Lacerda
Journal:  JIMD Rep       Date:  2015-08-25

10.  Induced pluripotent stem cell models of Zellweger spectrum disorder show impaired peroxisome assembly and cell type-specific lipid abnormalities.

Authors:  Xiao-Ming Wang; Wing Yan Yik; Peilin Zhang; Wange Lu; Ning Huang; Bo Ram Kim; Darryl Shibata; Madison Zitting; Robert H Chow; Ann B Moser; Steven J Steinberg; Joseph G Hacia
Journal:  Stem Cell Res Ther       Date:  2015-08-29       Impact factor: 6.832

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.